Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - COST OF REVENUE
Cost of Revenue AVTX - Avalo Therapeutics, Inc.
1.28 M
LAST VALUE
-7.20%
2 YEAR CAGR
-29.70%
5 YEAR CAGR
0.00%
10 YEAR CAGR